Timing & pharmacokinetics
How long does Kratom (Mitragyna speciosa) take to work?
Onset timing for Kratom (Mitragyna speciosa) varies in the clinical literature. Onset timing is not well-quantified in our dataset, refer to clinical citations on the main entry.
Onset
–
Half-life
–
Duration
–
Timing
anytime
Key facts
- typical dose
- 1000–8000 mg
- dose frequency
- as needed
- timing
- anytime
- with food
- optional
- safety score
- 2/5
- evidence grade
- C
- class
- stimulant
- PubMed citations
- 800
- legal status (US)
- Unscheduled (legal)
- legal status (UK)
- Research-chemical category
- legal status (EU)
- Prescription-only
- legal status (AU)
- Banned
- restrictions
- AU; Thailand (since 1943, partially); Multiple US states
- primary mechanism
- Primary alkaloid mitragynine is a partial agonist at mu-opioid receptors with biased signaling, produces analgesia and mood elevation with less respiratory depression than classical opioids.
Onset window
Kratom (Mitragyna speciosa) onset times in the published literature vary widely. Refer to the citations on the main Kratom (Mitragyna speciosa) entry for compound-specific pharmacokinetic data.
Food effect: Food has only modest effect on Kratom (Mitragyna speciosa) onset. Take with or without food depending on GI tolerance.
Half-life and dosing frequency
Half-life is not characterised in our dataset.
Acute vs. chronic effect
Some nootropics work the first time you take them (Kratom (Mitragyna speciosa) may or may not). Others, adaptogens, racetams, and most botanicals targeting BDNF or NGF pathways, require 2–4 weeks of daily dosing before the full effect emerges.
If you don’t feel anything after a single dose and the compound is in the chronic-effect category, that is normal, extend the trial to 2–4 weeks before evaluating. If it is in the acute category and you feel nothing, consider dose, vendor sourcing, or whether the compound matches your goal.
Protocol note from the Kratom (Mitragyna speciosa) entry
Significant abuse and dependence potential. Banned in multiple jurisdictions.
Mechanism, safety, and citations for Kratom (Mitragyna speciosa) are on the main reference page, see Kratom (Mitragyna speciosa). For full dose protocol see Kratom (Mitragyna speciosa) dosage. To check for stack-level pharmacokinetic conflicts, use the interaction checker.
Onset and pharmacokinetic data reflect the published literature for healthy adults at typical doses. Individual variation in absorption, metabolism (CYP genotype), and gut transit can shift onset by ±50%. This page is informational and not medical advice. See our full disclaimer.